Neurological

the NeuroCOVID-19 Process Drive of the EAN

Coronavirus disease 2019 (COVID-19), a multi-organ disease caused by the severe coronavirus 2 (SARS-CoV-2) with acute respiratory syndrome, continues to pose challenges to health and care systems worldwide. The pandemic has disrupted acute neurological services and routine patient care and affected the clinical course in patients with chronic neurological diseases. COVID-19 appears to have exposed inequalities between societies and health systems and has had a disproportionate impact on communities already at risk.

The next challenge will be to put initiatives in place to eliminate differences in all aspects related to COVID-19. From a medical point of view, inequalities in terms of prevention, treatment and long-term consequences need to be considered. Some of the topics directly relevant to neurologists are summarized.

With this assessment, the Task Force NeuroCOVID-19 of the European Academy of Neurology intends to raise awareness of the possible impact of COVID-19 on inequalities in health care and calls for measures to prevent disparities at the individual, national and supranational levels.

Related Articles